Goal-directed Analgesia Using ANI During General Anesthesia in Children With Moyamoya Disease
Not Applicable
Recruiting
- Conditions
- Pain
- Interventions
- Registration Number
- NCT05672212
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Analgesia Nociception Index (ANI) has been proposed for the evaluation of the nociception-antinociception balance in the perioperative period. In pediatric patients with Moyamoay disease, where the management of analgesia may be rendered difficult by pharmacological changes, we hypothesised that the monitoring of analgesia with ANI would reduce intraoperative opioid consumption during EDAS surgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
- Pediatric patients receiving EDAS surgery for Moyamoya disease
Exclusion Criteria
- ASA (American society of anesthsiologists classification) 4-5
- Emergency surgery
- patients with chronic pain on medication
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ANI (Analgesia/Nociception Index) monitoring ANI (Analgesia/Nociception Index) monitoring - ANI (Analgesia/Nociception Index) monitoring Sufentanil - Standard monitoring standard monitoring - Standard monitoring Sufentanil -
- Primary Outcome Measures
Name Time Method the mean hourly intraoperative sufentanil requirement from induction of anesthesia to end of operation, about 5 hours
- Secondary Outcome Measures
Name Time Method the amount of non-opioids analgesic requirements from induction of anesthesia to end of operation, about 5 hours the amount of vasoactive agents requirements from induction of anesthesia to end of operation, about 5 hours
Trial Locations
- Locations (1)
Seoul national university hospital
🇰🇷Seoul, Korea, Republic of